# GLIAMED INC — Form D

GLIAMED INC of Framingham, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-04. The offering totals $28.9M, of which $2.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2009-05-04
- Form: D
- Accession: 0001440513-09-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $28.9M
- Amount sold: $2.5M
- Remaining: $26.4M
- Investors: 1
- Date of first sale: 2008-05-22
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-120434

## Issuer

- Name: GLIAMED INC
- CIK: 0001440513
- Entity type: Corporation
- Jurisdiction: DE
- Address: 495 Old Connecticut Path, Suite 320, Framingham, MA, 01701
- Phone: 5086260077

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Andrew Busser | Director | New York, NY |
| Barry Dickman | Director | San Jose, CA |
| Andrew Uprichard | Director | Framingham, MA |
| David Weinstein | Director | Boca Raton, FL |
| Andrew Uprichard | Executive Officer | Framingham, MA |

## More

- [CIK 1440513 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1440513&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001440513-09-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.